Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Abdominal Epilepsy

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Abdominal Epilepsy in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukata, Y1
Adesnik, H1
Iwanaga, T1
Bredt, DS1
Nicoll, RA1
Fukata, M1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Abdominal Epilepsy

ArticleYear
Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission.
    Science (New York, N.Y.), 2006, Sep-22, Volume: 313, Issue:5794

    Topics: ADAM Proteins; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Calcium Channels;

2006